Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome

Table 3

Cox regression analysis of MACEs in whole, nondiabetic, and diabetic patients.

Variable	Univariate analysis			Multivariate analysis
	Hazard ratio (95% CI)	SEM	value	Hazard ratio (95% CI)	SEM	value
Whole
MCV-L	Reference		0.032	Reference		0.032
MCV-M^b	0.899 (0.577-1.401)	0.226	0.638	1.159 (0.662-2.028)	0.286	0.606
MCV-H^b	1.540 (1.038-2.284)	0.201	0.032	1.870 (1.113-3.144)	0.265	0.018
Non-DM
MCV-L	Reference		0.032	Reference		0.032
MCV-M^b	1.487 (0.827-2.673)	0.299	0.185	1.223 (0.574-2.606)	0.386	0.415
MCV-H^b	1.963 (1.180-3.265)	0.260	0.009	2.089 (1.077-4.501)	0.338	0.029
DM
MCV-L	Reference		0.328
MCV-M^b	1.368 (0.695-2.692)	0.345	0.364
MCV-H^b	1.795 (0.816-3.950)	0.402	0.146

MACEs: major adverse cardiovascular events; MCV: mean corpuscular volume; DM, diabetes mellitus; CI: confidence interval; SEM: standard error of measurement. Adjusted for age, sex, body mass index, smoking, past myocardial infarction, hypertension, creatinine, creatine kinase isoenzymes, pro-B-type natriuretic peptide, and left ventricle ejection fraction. ^bCompared with MCV-L group.